chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 60 year old patient who on 30-JUL-2008 was inadvertently vaccinated with VARIVAX (Oka/Merck) instead of ZOSTAVAX (Oka/Merck) (MSD).  The medication error did not result in any adverse symptoms.  The physician confirmed it was a human error but not a product confusion.  It was unspecified if the patient sought medical attention.  Additional information has been requested.
Patinet reported having fever, generalized muscle pain and nausea following the vaccine.  Reported mild soreness in arm but could still raise arm over head.
Immediately after vaccine, patient complained of throat "itching" and feeling as though her throat and tongue was swelling. Transported to hospital via ambulance. Unsure of which hospital transported to.
pt recv vax & devel a prolonged illness described as muscle soreness, gen weakness, loss of balance, nausea & severe joint pain;
Within 4-5 hours after injection noticed soreness, slight swollen, tender to touch. 24-30 hours later obvious redness, warm to touch, remains sl swollen, but less soreness.
Information has been received from a registered nurse regarding a patient of an unknown age and gender. On 23-OCT-2013 at 17:30, ZOSTAVAX lot # J004268 was exposed to -14C for an estimated total time out of range of 10.0 hours. On 25-OCT-2013 at 18:30, ZOSTAVAX lot # J004268 was exposed to an exact T not recorded but noted as equal to or >12C for an estimated total time out of range of 10.5 hours. On 06-NOV-2013, the patient was vaccinated with an out of range dose of ZOSTAVAX (dose and route administration were not provided) (Lot number J004268, Exp. Date: 12-JUL-2014). No adverse experience had been reported. This is one of 182 reports from the same source. Additional information has been requested.
8 hours after injection severe arm pain developed, unable to lift arm. Low grade fever, neck and back pain, and chills 14 hours after injection. Next morning right-sided supraclavicular and deep cervical chain lymph node swelling were noted (which is the reason for reporting). Never happened with previous vaccines.
Within a few minutes of receiving the vaccine, the patient turned pale and clammy. He became confused and lost consciousness for several seconds, his head fell back and he made gurgling noises. When he regained consciousness, he couldn't remember our conversation. He said he was hot and his head hurt for a few minutes, he remained pale and sweaty for several minutes. After 10-15 minutes he said he felt fine.
I received post nasal drip; light sore throat;  shortness of breath for 3 days and I took Paxlovid and the symptoms  have not resolved.
Shingles outbreak 5 days after vaccination; This is a spontaneous report from a contactable other healthcare professional. A 48-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number: EL0140), intramuscular on 22Dec2020 at single dose on the right arm for COVID-19 immunization. The patient is not pregnant at the time of vaccination. The patient's medical history and concomitant medications were not reported. The patient previously took morphine and experienced allergies. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. COVID-19 vaccine was administered in the hospital.  The patient experienced shingles outbreak 5 days after vaccination on 27Dec2020. The event was assessed as non-serious. Acyclovir pills were given as treatment. Since the vaccination, the patient has not been tested for COVID-19. It was also reported that "Did the adverse event result in any of the following?: Doctor or other healthcare professional office/clinic visit". Outcome of the event was not recovered.
flu SHOT GIVEN 10/25/07  General feelig of malaze on Saturday and Sunday following.  Little inpact on activities.  Monday AM head ache, chills, able to complete workday.  Tuesday severe head ache, chills able to complete workday.  Tuesday night diarreha, vomiting (dry heaves).  Wednesday home in bed.  Severe head ache, chills, no further diarreha or vomiting.  Thursday temp 101.1 @ 5am (first taken)  stayed home in bed same symptoms. temp 100.8 @ 1pm. Reported sickness to company Nurse.  Friday more of the same, Missed work. temp over 100 all day.  Seen by primary care provider at military clinic.  Diagnosis: flu symptoms. Saturday and Sunday home continued head ache, chills, fever.  Monday (Nov 5)returned to work with head ache and chills all day. Went from 205 pounds to 195 pounds over course of the period.
Day 1 was dizziness and haziness, then pain and exhaustion. Night 1 was fever, shakes, chills, uncontrollable bowels. Day 2 was a POUNDING headache in my eyes, sides of my head, swollen lymph nodes, and on my jaw. Night 2 was sweats and nausea. Day 3 was coughing and mucus as well as muscle pain.
Can not sleep without noise masking device; Tinnitus started with right ear and was in both ears the following day; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TINNITUS (Tinnitus started with right ear and was in both ears the following day) and INSOMNIA (Can not sleep without noise masking device) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21Q) for COVID-19 immunisation.     Concurrent medical conditions included Penicillin allergy.    On 15-Mar-2021 at 11:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021 at 4:00 PM, the patient experienced TINNITUS (Tinnitus started with right ear and was in both ears the following day). On an unknown date, the patient experienced INSOMNIA (Can not sleep without noise masking device). The patient was treated with PREDNISONE for Tinnitus, at an unspecified dose and frequency and Physical therapy for Tinnitus. At the time of the report, TINNITUS (Tinnitus started with right ear and was in both ears the following day) had not resolved and INSOMNIA (Can not sleep without noise masking device) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       Patient was given hearing aids to create background noise as corrective. Patient underwent hearing tests, however the findings were not reported. Patient reported that as per the specialist the tinnitus was probably permanent.   No concomitant medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Follow-up received information contains Patient's demographic details, medical history, vaccine start date and new event insomnia was added. Treatment medication specified.
She developed R should pain, arm numbness and difficulty with grasp.  It has slowly improved but she still has symptoms periodically. (per MD note)
Child spiked a fever of 102.7 that was not mitigated with Tylenol. Fever was detected the following morning after the vaccines were administered.
CHILLS; 104+ FEVER; TERRIBLE HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a male of unspecified age, race and ethnicity. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, route of admin, and batch number were not reported, expiry: UNKNOWN) dose was not reported, 1 total administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced terrible reaction: chills, 104+ fever (for four days), terrible headache, and nausea (Dose number in series 1). Laboratory data (dates unspecified) included: Body temperature (NR: not provided) 104+ F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from 104+ fever, and the outcome of terrible headache, chills and nausea was not reported. This report was non-serious. This case, involving the same patient is linked to 20220130224 (Dose number in series 2) .
Within 10-15 minutes after getting the vaccination the patient developed itching and a rash to the left arm. She states that due to her seasonal allergies she carried BENADRYL and CLARITIN with her. She took both medicines and the itchy spots resolved within a few hours.
Five days after 2nd dose which was on 07.23.2021 my left side went completely paralyzed waste up. Could not feel my left side arms, back, breast, fingers, hands. Had hard time breathing and pain that was unbearable. Still have no feeling in two fingers, I have a bone sticking out from under my armpit, my left breast is in pain can not even touch it, my upper left side of back is constantly cracking, have sharp pains in entire left side, tingling pins and needles all day on left side, left elbow takes 1 hour to open up in the am, stabbing in back on bi sap, triceps, and shoulder. Basically my left side is not working
Reconstituted incorrectly, only given the Lyophilized MenA component and reconstituted in sterile water. Patient reports no reactions or symptoms.
Muscle Aches; Chills; Pain at site; Redness; itching at insertion site; This case was reported by a consumer via call center representative and described the occurrence of muscle pain in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis.   On 29th January 2020, the patient received the 2nd dose of Shingrix. In January 2020, less than a week after receiving Shingrix, the patient experienced muscle pain, chills, injection site pain, injection site erythema and injection site itching. On an unknown date, the outcome of the muscle pain, chills and injection site pain were recovered/resolved and the outcome of the injection site erythema and injection site itching were not recovered/not resolved.   It was unknown if the reporter considered the muscle pain, chills, injection site pain, injection site erythema and injection site itching to be related to Shingrix.  Additional details were received as follows: The age at vaccination was not reported but could be 67 or 68 years. The reporter stated that the patient had muscle pain, chills and injection site pain after vaccination. The patient also had redness and itching at insertion site. The reporter asked what is the pathology that causes side effects with the second shot. The reporter did not consent to follow up. This case is 1 out of 3 cases reported by the same reporter.
Initial report received from a reporter (other) on 24-Sep-2013: A female patient (age unknown) had received intramuscular (IM) ADACEL vaccine (lot # C4456AA and expiration date unknown) on right deltoid on 20-Sep-2013. Within next few days, she has experienced 3.5 inch around, red, swollen, hot to touch, itchy, area at injection site of right arm. The patient continue to experience these symptoms to today, 24-Sep-2013. The patient's medical history includes allergic to Penicillin. Documents held by sender: non.
Pain at location of vaccine shot on left arm, pain runs from left shoulder down my arm to my fingers, arm becomes numb. Lots of pain to move arm around, pain also runs to my chest area. numbness in arm n left side of body.
flu like symptoms; body aches; headache; swollen sore throat like strep throat; swollen sore throat like strep throat; runny nose; some stomach issues; chills; fever; This is a spontaneous report from a contactable consumer (patient). This 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number unknown) via an unspecified route of administration on 07Apr2021 as a single dose for COVID-19 immunisation. Medical history included COVID from Dec2020 and unknown if ongoing. Concomitant medications were not reported. The patient called about information on how long symptoms would last and if there was anything that could be taken. She reported having flu-like symptoms; she stated she went to the doctor and they didn't help and wouldn't suggest anything. The patient reporting having body aches, headache, swollen sore throat like strep throat, and a runny nose. She stated she got the vaccine first on 07Apr (2021) and the following day is when she started feeling like she had corona again. She reported that as time went by she started having some stomach issues that went away. She reported that chills and fever went away and that now (as of 13Apr2021) the headache and swollen throat and like a flu were "trying to catch on." The clinical outcomes of flu like symptoms, body aches, headache, swollen sore throat like strep throat, and runny nose were unknown. The outcomes of some stomach issues, chills and fever were recovered in Apr2021.  The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.
Administration error: this patient was scheduled to receive MCV4 but instead received MenB at the age of 13 years old when recommended age is 16-18. Trumenba is approved to be given as young as 10 years old, if the person is at high risk but that is not the case for this patient. No adverse effects were noted after administration and none have been reported by the parent. Our medical provider and the CDC find no health risk. Our medical provider has decided that the patient will not receive the second dose at this time and will be re-vaccinated at 16 years of age to provided adequate protect as 16-18 is the age of higher risk. This patient will be returning to our clinic on 03/08/2021 to receive MCV4.
On Jan. 4th, woke up with welts on my lower jaw which came and went throughout the day. It was worse on Jan. 5th, by evening it had spread gradually up to my forehead.  Mildly raised welts. Treated with repeated applications of topical benadryl.  On Jan. 6th, had welts again, but was not as bad. Since that time I get itchiness and small welts on my jawline and under my left arm. It comes and goes. I had other side effects: On 12/30 and 12/31: severe pain in my L arm. Also sore throat and body aches for several days. On Jan 1 and a couple times a week,  I have short dizzy spells, just a few seconds.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 20-FEB-2019, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number N034400 with expiration date in 10-MAY-2019) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1906USA011434: US-009507513-1907USA001847: US-009507513-1907USA001849: US-009507513-1907USA001848: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001810: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA000952: US-009507513-1907USA000953: US-009507513-1907USA000954: US-009507513-1907USA000959: US-009507513-1907USA000962: US-009507513-1907USA000963: US-009507513-1907USA000964: US-009507513-1907USA000965: US-009507513-1907USA000966: US-009507513-1907USA000967: US-009507513-1907USA000968: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000988: US-009507513-1907USA000989:
Had a stiff neck and arm; Neck pain moving up to the back of my head; Sometimes I can't lift my arm; This spontaneous case was reported by a consumer and describes the occurrence of MUSCULOSKELETAL STIFFNESS (Had a stiff neck and arm), NECK PAIN (Neck pain moving up to the back of my head) and MOBILITY DECREASED (Sometimes I can't lift my arm) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MUSCULOSKELETAL STIFFNESS (Had a stiff neck and arm), NECK PAIN (Neck pain moving up to the back of my head) and MOBILITY DECREASED (Sometimes I can't lift my arm). At the time of the report, MUSCULOSKELETAL STIFFNESS (Had a stiff neck and arm), NECK PAIN (Neck pain moving up to the back of my head) and MOBILITY DECREASED (Sometimes I can't lift my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Treatment medication information was provided. No concomitant medication information was provided.
Large red area that - swollen and itchy which occurred approximately 12-18 hours after receiving vaccine.
At some time after the vaccines were given I started having muscle aches and pains throughout my body.  Thighs, calves, butt, hips, biceps, forearms, and inside area between bicep and lower arm (opposite side of elbow) which would keep me awake at night due to the pain.  That pain was only at night, the other pains were during the day and most times would last the whole day, but other times would lessen as the day went on.  I still cannot sleep on my left side, due to hip and arm pain, but the very painful left arm pain persists as described above even when sleeping on my right side.  I still have these pains as of the date of this writing, April 17, 2021.
None- vaccine given 16 days post expiry; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (None- vaccine given 16 days post expiry) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (None- vaccine given 16 days post expiry). On 22-Nov-2021, EXPIRED PRODUCT ADMINISTERED (None- vaccine given 16 days post expiry) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-395985 (Patient Link).
allergic rxn, redness, swelling, hot inflamed area of inj;lost 2 days of school;cellulitis (muscle stiff);
pt recv vax; r n reported pt passed out & exp "oth AE" following vax;reporter felt there was problem w/ the particular lot;
This case was reported by a physician via sales representative and described the occurrence of fever in a 6-week-old subject of unspecified gender who was vaccinated with PEDIARIX (GlaxoSmithKline), PREVNAR (non-gsk), ACTHIB (non-gsk) and ROTATEQ (non-gsk). On approximately 25 August 2011 the subject received 1st dose of PEDIARIX (.5 ml, unknown, unknown thigh), 1st dose of PREVNAR (unknown, unknown thigh), 1st dose of ACTHIB (unknown, unknown thigh), and 1st dose of ROTATEQ (unknown). On 25 August 2011, within 24 hours of vaccination with PEDIARIX, ACTHIB, PREVNAR and ROTATEQ, the subject experienced fever of 100.5 or 102 degrees Fahrenheit and fussiness. The subject was hospitalized for two days; discharged no sequelae according to hospital protocol and no sepsis. On 26 August 2011, the fever and fussiness were resolved. The physician considered the fever and fussiness possibly related to vaccination with PEDIARIX. Another case was reported please see A0945514A.
11 y with two doses of MMR 1/8/93 and 8/16/96. Seen in office on 3/31/03 with parotitis. Possible vaccine failure suspected, probable mumps suspected. F/U in three days.
This spontaneous report was received from a licensed practical nurse referring to multiple patients of unknown age and gender. The patients' medical history, concurrent conditions and concomitant therapies were not reported. On multiple unknown dates, the patients were vaccinated with doses of ROTATEQ for prophylaxis, (orally; dose, lot# and expiration dates were not reported). No adverse effects were reported. There were no previous temperature excursions; the data logger reported: "traceable Min. and Max." There was no Product Quality Complain (PQC) involved. This is one of several reports from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1612USA013204: US-009507513-1612USA013205: US-009507513-1612USA013206: US-009507513-1612USA013207:
On 3 rd day after vaccine started to have flash red ears for few days. After 3 weeks of vaccine started to have tinnitus , which I have never had before. Still suffering
Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Soreness) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced PAIN (Soreness). At the time of the report, PAIN (Soreness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medications were reported No concomitant medications were reported
Left arm swelling after administration of Hep A and HPV in that arm. Seen in office. Symptomatic core recommended.
Received vaccine approx 2 pm Friday Sept 29 2023. Woke up with intense dizziness and slight nausea at 4:15 am on Saturday Sept 30 2023. Dizziness persisted for approx 24 hours. Took Tylenol 8hr tablet to ease headache accompanying dizziness
Feeling of passing out tingly all over Racing heart pulse 160 Weakness drowsiness Throat dryness
Rash over entire body. Progressed to hives.. In 5th day hives are gone but  rash increased  with rash spots  melding with each other for continuous red. Accompanied with headaches, tiredness, fatigue, nausea